STATCelgene now owns a checkpoint inhibitor for solid tumors, but is Beigene deal too late for cancer immunotherapy race?STATCelgene says securing ownership of a checkpoint inhibitor is important for its cancer immunotherapy plans for solid tumors. But… Continue reading
|
UTSW Finds ‘Combination Immunotherapy‘ Is Effective For Battling Kidney Cancer
D Healthcare Daily UT Southwestern researchers have found combining two immunotherapy drugs can help treat kidney cancer. According to a new study, the effect of this combination therapy produced an “unprecedented doubling of response rates from 20 to 40 percent.”. |
BOB fm (press release) |
Leukaemia survivor becomes Hertfordshire stem cell donor’s Best Man
BOB fm (press release) A stem cell donor from Hertfordshire is encouraging more people to sign up and save a life, after he found his Best Man by doing so… In 2006, Paul Rogers from Pirton near Hitchin donated his stem cells to a stranger: Brett Dingwall, who had been … |